Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680836 · ClinicalTrials.gov registry record · NA
Gulf War Digestive Health Study
A NA study of Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT00680836 is a NA study of Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 54 participants, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00680836, a NA study of Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The purposes of this study are to estimate the burden of disease due to chronic gastrointestinal illness in PG veterans, to evaluate whether Small Bowel Bacterial Overgrowth (SBBO) is associated with chronic diarrhea in PG veterans, and to determine whether eradication of SBBO reduces symptoms of chronic diarrhea, abdominal pain and bloating in PG veterans.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Rifaximin
Study Locations (1)
Utah
- Division of Epidemiology - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2007-10 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680836
The ClinicalTrials.gov registry entry for NCT00680836 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (62% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00680836 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT00680836 about?
NCT00680836 is a clinical study titled "Gulf War Digestive Health Study". The purposes of this study are to estimate the burden of disease due to chronic gastrointestinal illness in PG veterans, to evaluate whether Small Bowel Bacterial Overgrowth (SBBO) is associated with chronic diarrhea in PG veterans, and to determine whether eradication of SBBO reduces symptoms of ch...
What is the current status of trial NCT00680836?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2007-10. Estimated completion is 2013-12.
What conditions does trial NCT00680836 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth.
What interventions are being tested in trial NCT00680836?
The interventions under investigation include: Placebo (DRUG), Rifaximin (DRUG).
Who is sponsoring clinical trial NCT00680836?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00680836 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
GI Alpha-Gal Study
RECRUITING · NA
-
Visible Abdominal Distension
RECRUITING · NA
-
IBS Skin Patch Test Food Allergy Study
RECRUITING · NA
-
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
RECRUITING · NA
-
Well-being in IBS: Strengths and Happiness (WISH) 2.0
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.